483
Burgwedel Biotech GmbHBurgwedel Biotech GmbH – FDA 483, Aug 29, 2023
Record Details
Burgwedel Biotech GmbH, a biologics vaccine manufacturer, was cited for failing to justify deviations from written sampling plans and test procedures. The inspection revealed a lack of thorough review for unexplained discrepancies from their contract testing lab concerning stability studies for the ERVEBO vaccine. This included multiple instances of missed stability time points, use of expired media, and sample mismanagement, indicating inadequate oversight of critical outsourced testing.
View Company Profile
ID · 168e6164-0118-4d7b-a630-41ce46251ecb
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.